April 4, 2012 Third Annual Patient-Reported Outcome Consortium Workshop April 4, 2012 Sheraton Silver Spring Hotel 8777 Georgia Avenue – Silver Spring, MD 20910 SPONSORED BY: Critical Path Institu
House Energy and Commerce Committee Hearing C-Path’s work was positively acknowledged by Dr. Janet Woodcock during the April 18 House Energy and Commerce Committee Hear
Critical Path Institute Announces New Board Members Critical Path Institute (C-Path) is proud to welcome four new board members who were recently elected to serve three-year terms (2
Critical Path Institute Honors World Tuberculosis Day 2012 Tuberculosis (TB) is often thought to be a disease of the past. The reality: Because no new therapies for TB have been developed i
Could Genetics Improve Warfarin Dosing? In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of th
Critical Path Institute Announces New CEO Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chi
European Medicines Agency Deems Imaging Biomarker a Qualified Measure to Select Patients with Early Stages of Cognitive Impairment for Alzheimer’s Disease Clinical Trials Based on a request for regulatory review by Critical Path Institute’s (C-Path) Coalition Against Major Diseases (CAMD), the
C-Path Recognized in One of The National Institute of Mental Health’s Top 10 Research Advances of 2011